Phase II Study of BNC210 in PTSD
Public ClinicalTrials.gov record NCT02933606. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Phase II Study of BNC210 in Adults With Post-Traumatic Stress Disorder (PTSD).
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, placebo-controlled study, evaluating the effects of BNC210 versus placebo on the symptoms of Post-Traumatic Stress Disorder, as measured by the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). The secondary objectives of the study are to evaluate the effects of BNC210 on anxiety, depression, global functioning and patient reported outcomes in patients with PTSD. Safety and tolerability of BNC210 will also be assessed. Study participants will receive 12 weeks of blinded treatment followed by a 3 week follow-up period.
Study identification
- NCT ID
- NCT02933606
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 193 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2016 (Actual)
- Primary completion
- Jul 5, 2018 (Actual)
- Completion
- Jul 25, 2018 (Actual)
- Last update posted
- Feb 27, 2023
2016 – 2018
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Oceanside | California | 92056 | — |
| Not listed | Rancho Mirage | California | 92270 | — |
| Not listed | Redlands | California | 92374 | — |
| Not listed | Riverside | California | 92506 | — |
| Not listed | Gainesville | Florida | 32607 | — |
| Not listed | Jacksonville | Florida | 32256 | — |
| Not listed | Lauderhill | Florida | 33309 | — |
| Not listed | North Miami | Florida | 33161 | — |
| Not listed | Oakland Park | Florida | 33334 | — |
| Not listed | Orlando | Florida | 32801 | — |
| Not listed | Hoffman Estates | Illinois | 60169 | — |
| Not listed | Overland Park | Kansas | 66211 | — |
| Not listed | New Bedford | Massachusetts | 02740 | — |
| Not listed | Lincoln | Nebraska | 68526 | — |
| Not listed | Las Vegas | Nevada | 89102 | — |
| Not listed | Berlin | New Jersey | 08009 | — |
| Not listed | Canton | Ohio | 44718 | — |
| Not listed | Memphis | Tennessee | 38119 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02933606, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 27, 2023 · Synced Oct 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02933606 live on ClinicalTrials.gov.